Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

D. A. Eichenauer; B. M.P. Aleman; M. André; M. Federico; M. Hutchings; T. Illidge; A. Engert; M. Ladetto

doi:10.1093/annonc/mdy080

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

D. A. Eichenauer
, B. M.P. Aleman
, M. André
, M. Federico
, M. Hutchings
, T. Illidge
, A. Engert
, M. Ladetto

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Lingua originale	Inglese
pagine (da-a)	iv19-iv29
Rivista	Annals of Oncology
Volume	29
DOI	https://doi.org/10.1093/annonc/mdy080
Stato di pubblicazione	Pubblicato - 1 ott 2018
Pubblicato esternamente	Sì

Accesso al documento

10.1093/annonc/mdy080

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{25af79fd8f7c40808efd53dc86f8650d,

title = "Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",

author = "Eichenauer, \{D. A.\} and Aleman, \{B. M.P.\} and M. Andr{\'e} and M. Federico and M. Hutchings and T. Illidge and A. Engert and M. Ladetto",

note = "Funding Information: MA has reported being an advisory board member of and received travel grants from Takeda and Bristol-Myers Squibb and research grant from Takeda; MH has reported being an advisor for and received research support from Takeda; TI received honoraria from Takeda; AE received honoraria from Takeda, Bristol-Myers Squibb and Amgen and research funding from Takeda,",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy080",

language = "English",

volume = "29",

pages = "iv19--iv29",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Hodgkin lymphoma

T2 - ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

AU - Eichenauer, D. A.

AU - Aleman, B. M.P.

AU - André, M.

AU - Federico, M.

AU - Hutchings, M.

AU - Illidge, T.

AU - Engert, A.

AU - Ladetto, M.

N1 - Funding Information: MA has reported being an advisory board member of and received travel grants from Takeda and Bristol-Myers Squibb and research grant from Takeda; MH has reported being an advisor for and received research support from Takeda; TI received honoraria from Takeda; AE received honoraria from Takeda, Bristol-Myers Squibb and Amgen and research funding from Takeda,

PY - 2018/10/1

Y1 - 2018/10/1

UR - https://www.scopus.com/pages/publications/85053592868

U2 - 10.1093/annonc/mdy080

DO - 10.1093/annonc/mdy080

M3 - Article

SN - 0923-7534

VL - 29

SP - iv19-iv29

JO - Annals of Oncology

JF - Annals of Oncology

ER -